The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Launched by ENDOLOGIX · Mar 11, 2024

Keywords

ClinConnect Summary

The Percutaneous Transmural Arterial Bypass -1 Study is looking at how well a new treatment called the DETOUR System works for people with peripheral arterial disease, which causes poor blood flow in the legs and can lead to pain and other problems. This study focuses on patients who have specific types of blockages in their leg arteries that make them less suitable for traditional surgeries or other treatments. The goal is to gather information on how this system performs in real-life situations for patients with certain conditions affecting their femoropopliteal arteries, which are located in the thigh and knee.

If you or a loved one has been diagnosed with this condition and your doctor thinks you might benefit from the DETOUR System, you may be eligible to participate in the study. There are no specific restrictions on who can join, so as long as your doctor believes you are a suitable candidate, you can take part. Participants will help researchers understand the effectiveness of this new treatment by allowing their cases to be monitored and documented over time. This study is currently recruiting patients, and it offers a chance to contribute to important medical research while exploring a potentially helpful option for managing your condition.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: Participants should be a candidate for the DETOUR System as assessed by the treating physician after review of the clinical and anatomic Indications for Use.
• • -
• • Exclusion Criteria: There are no exclusion criteria. All cases entered in the registry at participating institutions will be included up through the targeted goals per the enrollment plan.
• • -